NCT05430698: PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 62 planned
- Started
- 31 Jan 2023
- Primary completion
- 31 Jan 2027
- Arms
- PD-1antibody plus GEMOX
- Results
- None posted
- 24 Jun 2022: Trial registered
- 31 Jan 2023: Trial started